|
|
.
See Category: Diseases of the digestive system
See Header: Crohn's disease of large intestine with complications
ICD-10 (CM) Code and Descriptor
|
K50.112 |
Crohn's disease of large intestine with intestinal obstruction
|
K50112 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 63.96%
|
17.13%
|
8.46%
|
4.23%
|
2.32%
|
1.23%
|
0.89%
|
0.20%
|
0.14%
|
0.34%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for K50.112*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
226
|
226
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
217
|
217
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
210
|
227
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
200
|
200
|
|
80053
|
COMPREHEN METABOLIC PANEL |
195
|
195
|
|
J3380
|
INJ VEDOLIZUMAB IV 1 MG |
188
|
55,802
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
167
|
168
|
|
96413
|
CHEMO IV INFUSION 1 HR |
160
|
160
|
|
86140
|
C-REACTIVE PROTEIN |
152
|
152
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
126
|
4,268
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
114
|
288
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
113
|
5,280
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
111
|
119
|
|
45380
|
COLONOSCOPY AND BIOPSY |
74
|
74
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
69
|
100
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
58
|
62
|
|
85652
|
RBC SED RATE AUTOMATED |
57
|
57
|
|
85027
|
COMPLETE CBC AUTOMATED |
56
|
56
|
|
80076
|
HEPATIC FUNCTION PANEL |
53
|
53
|
|
80048
|
METABOLIC PANEL TOTAL CA |
47
|
47
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
K50.112 related to the following DRG Codes:
385-387
|
